Hepatitis B Vaccination Deaths Lead To Decline In Vietnam Infant Program
This article was originally published in PharmAsia News
Executive Summary
Vietnam has pulled back from vaccinating infants against hepatitis B after a newly inoculated baby died. The Ministry of Health said the child died six hours after it was injected with a vaccine. A provincial health department suspended use of the batch from which the vaccine came and ordered an investigation of the vaccination process. Ten infants have died since 2007 after receiving the vaccine, leading to a sharp drop from more 64.3 percent of babies vaccinated against hepatitis B in 2006 to 23.9 percent in 2008. (Click here for more
You may also be interested in...
Alvotech Highlights Lack Of Simponi Rivals As It Delivers Golimumab Results
Alvotech has just become the first company to announce positive topline results from a confirmatory clinical study for a proposed golimumab rival to Simponi and Simponi Aria – and moreover, the firm sees limited competition from other biosimilars on the horizon.
Xbrane Assembles The Troops As FDA Says No To Lucentis Biosimilar
Xbrane Biopharma was riding the crest of a wave with the EU launch of its biosimilar to Lucentis, following years of toil and investment. However, plans to roll out the product in the US will have to be pushed back – likely – into the middle of 2025, following a US FDA complete response letter.
UK MHRA Updates Assistive Tech And Borderline Regulations
Device classification themes were uppermost in April for the UK regulator, which issued key guidance in two areas prone to complexities. It also contributed to the MedTech Directorate’s one-year progress report.